01.12.2021 15:00

Ashland (ASH) to Hike Prices of 1,4-Butanediol & Derivatives

Folgen
Werbung
Ashland Global Holdings Inc. ASH announced that it is increasing the price of 1,4-Butanediol and various derivative products in North America.The company is increasing the price of 1,4 butanediol by 45 cents per pound. The price hike of both n-methyl-pyrrolidone, 2-pyrrolidone and tetrahydrofuran is 50 cents per pound.The company is increasing the prices of gamma-butyrolactone by 60 cents per pound.The price hikes are effective from Jan 1, 2021, or as agreements allow. Micropure and other specialty grades or packaged material might carry a bigger price hike.Shares of Ashland have gained 35.6% in the past year compared with a 7.9% rise of the industry.Image Source: Zacks Investment ResearchIn its last earnings call, Ashland, stated that it expects sales in the range of $2.25-$2.35 billion for fiscal 2022. It also anticipates adjusted EBITDA between $550 million and $570 million.The company noted that it projects improving demand across its businesses with no change in its underlying operating performance for fiscal 2022. It expects cost inflation along with supply chain issues. The company also anticipates the execution of its strategy, demonstration of organic growth, improvement in margins and enhanced free cash flow generation in fiscal 2022.Ashland Global Holdings Inc. Price and Consensus  Ashland Global Holdings Inc. price-consensus-chart | Ashland Global Holdings Inc. Quote Zacks Rank & Key PicksAshland currently carries a Zacks Rank #3 (Hold).Some better-ranked stocks in the basic materials space are Nucor Corporation NUE, The Chemours Company CC and Celanese Corporation CE.Nucor has an expected earnings growth rate of 583.2% for the current year. The Zacks Consensus Estimate for current-year earnings has been revised 7.7% upward in the past 60 days.Nucor beat the Zacks Consensus Estimate for earnings in two of the last four quarters, while missing the same twice. The company has a trailing four-quarter earnings surprise of roughly 2.74%, on average. The stock has surged around 92.8% in a year. NUE currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.Chemours has an expected earnings growth rate of 105.1% for the current year. The Zacks Consensus Estimate for the current year has been revised 10% upward in the past 60 days.Chemours beat the Zacks Consensus Estimate for earnings in all of the last four quarters. The company has a trailing four-quarter earnings surprise of roughly 34.2%, on average. CC has increased around 16.5% over a year. CC currently carries a Zacks Rank #2.Celanese has a projected earnings growth rate of 139.5% for the current year. The consensus estimate for the current year has been revised 8.8% upward in the past 60 days.Celanese beat the Zacks Consensus Estimate for earnings in each of the last four quarters. CE has a trailing four-quarter earnings surprise of 12.7%, on average. The company’s shares have gained around 15.9% in a year. It currently carries a Zacks Rank #2.Zacks Names "Single Best Pick to Double"From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.You know this company from its past glory days, but few would expect that it's poised for a monster turnaround. Fresh from a successful repositioning and flush with A-list celeb endorsements, it could rival or surpass other recent Zacks' Stocks Set to Double like Boston Beer Company which shot up +143.0% in a little more than 9 months and Nvidia which boomed +175.9% in one year.Free: See Our Top Stock and 4 Runners Up >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Nucor Corporation (NUE): Free Stock Analysis Report Ashland Global Holdings Inc. (ASH): Free Stock Analysis Report Celanese Corporation (CE): Free Stock Analysis Report The Chemours Company (CC): Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research
Weiter zum vollständigen Artikel bei "Zacks"
Quelle: Zacks

Nachrichten zu Ashland Global Holdings Inc

  • Relevant
  • Alle
  • vom Unternehmen
  • Peer Group
  • ?

Um Ihnen die Übersicht über die große Anzahl an Nachrichten, die jeden Tag für ein Unternehmen erscheinen, etwas zu erleichtern, haben wir den Nachrichtenfeed in folgende Kategorien aufgeteilt:

Relevant: Nachrichten von ausgesuchten Quellen, die sich im Speziellen mit diesem Unternehmen befassen

Alle: Alle Nachrichten, die dieses Unternehmen betreffen. Z.B. auch Marktberichte die außerdem auch andere Unternehmen betreffen

vom Unternehmen: Nachrichten und Adhoc-Meldungen, die vom Unternehmen selbst veröffentlicht werden

Peer Group: Nachrichten von Unternehmen, die zur Peer Group gehören

Analysen zu Ashland Global Holdings Inc

  • Alle
  • Buy
  • Hold
  • Sell
  • ?
29.03.2018Ashland Global OutperformBMO Capital Markets
31.01.2018Ashland Global NeutralMonness, Crespi, Hardt & Co.
16.05.2017Ashland Global BuyMonness, Crespi, Hardt & Co.
28.11.2016Ashland BuyDeutsche Bank AG
27.01.2016Ashland BuyMonness, Crespi, Hardt & Co.
29.03.2018Ashland Global OutperformBMO Capital Markets
16.05.2017Ashland Global BuyMonness, Crespi, Hardt & Co.
28.11.2016Ashland BuyDeutsche Bank AG
27.01.2016Ashland BuyMonness, Crespi, Hardt & Co.
23.09.2015Ashland BuyDeutsche Bank AG
31.01.2018Ashland Global NeutralMonness, Crespi, Hardt & Co.
04.01.2007Update Ashland Inc.: HoldMatrix Research
03.01.2007Update Ashland Inc.: HoldKeyBanc Capital Markets / McDonald
05.12.2006Update Ashland Inc.: NeutralJP Morgan
15.11.2006Update Ashland Inc.: NeutralCredit Suisse

Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar.

Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Ashland Global Holdings Inc nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"

Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"

Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen
Werbung
Werbung
Werbung
Werbung
Börse Stuttgart Anlegerclub
Werbung

Heute im Fokus

DAX gibt deutlich nach -- Accell von KKR übernommen -- Infineon sieht 2023 Ende der Chipkrise -- Evergrande, Lufthansa, Commerzbank, TUI im Fokus

Gorillas will französischen Essenslieferdienst Frichti übernehmen. Bundesnetzagentur erwägt Verzicht auf Mobilfunk-Auktion. Credit Suisse senkt Hannover Rück auf "Neutral" - Ziel 185 Euro. Haaland und Reus lassen BVB bei Hoffenheim jubeln - "überhaupt kein Zerwürfnis" zwischen BVB und Haaland. Hedgefonds Trian Partners will anscheinend mit Unilever-Beteiligung Druck machen.

Umfrage

Halten Sie es für richtig, dass die EZB an ihrer lockeren Geldpolitik festhält?

finanzen.net zero
finanzen.net zero

Oskar

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
Zur klassischen Ansicht wechseln